CHINA NATIONAL MEDICINES CORPORATION

Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd. (Fosun Wanbang Pharma Group) is a core member enterprise of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196-SH, 02196-HK). The company was established in 1981, earlier known as Xuzhou Biochemical Pharmaceutical Factory. In 1998, it was reorganized into Wanbang Biochemical Pharmaceutical; in 2001, it was changed to Fosun Wanbang Pharma Groupceutical. In 2004, Wanbang joined with Fosun Pharma; and in 2017, it was upgraded to Wanbang Biopharmaceuticals; In 2024, company name changed to Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd... Products of Fosun Wanbang Pharma Group market cover the fields of active chemical ingredients and their preparations, biochemical and biological products, traditional Chinese Medicine, etc. The company specializes in the research and development, production and sales of drugs in the treatment fields of hyperglycemia, hypertension, hyperlipidemia, hyperuricemia,..

Also known as: China National Accord Medicines Corporation Ltd., China National Medicines Corporation Ltd.